Cybin (HELP) Profit After Tax (2020 - 2026)
Cybin's (HELP) quarterly Profit After Tax came in at -$47.0 million in Q1 2026, up 40.35% YoY from -$33.5 million in Q1 2025, and down 10.14% on a QoQ basis from -$42.7 million in Q4 2025.
Cybin (HELP) Profit After Tax (2020 - 2026) Analysis & Trends
Cybin (HELP) has 7 years of Profit After Tax data on file, last reported at -$47.0 million in Q1 2026.
- Quarterly Profit After Tax rose 40.35% year-over-year to -$47.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$148.0 million (down 15.38% YoY) and the FY2026 annual result came in at -$148.0 million, down 81.35% from the prior year.
- Profit After Tax fell to -$47.0 million in Q1 2026, from -$42.7 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $19.8 million in Q1 2023 to a low of -$78.8 million in Q1 2025.
- A 5-year average of -$15.5 million and a median of -$1.2 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax soared 99.93% — and 2024, when it tumbled 472630.46%.
- Tracing HELP's Profit After Tax over 5 years: stood at -$10742.0 in 2022, then plunged by 107.4% to -$22278.5 in 2023, then plunged by 33739.86% to -$7.5 million in 2024, then sank by 465.96% to -$42.7 million in 2025, then retreated by 10.14% to -$47.0 million in 2026.
- The last three Profit After Tax figures came in at -$47.0 million (Q1 2026), -$42.7 million (Q4 2025), and -$33.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | -47.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.00 Mn |
| Dec 31, 2025 | -42.67 Mn |
| Sep 30, 2025 | -33.72 Mn |
| Jun 30, 2025 | -24.61 Mn |
| Mar 31, 2025 | -78.79 Mn |
| Dec 31, 2024 | -7.54 Mn |
| Sep 30, 2024 | -41.93 Mn |
| Jun 30, 2024 | -14,824.00 |
| Mar 31, 2024 | -1.24 Mn |
| Dec 31, 2023 | -22,278.46 |
| Sep 30, 2023 | -8,869.11 |
| Jun 30, 2023 | -10.80 Mn |
| Feb 28, 2023 | 19.80 Mn |
| Dec 31, 2022 | -10,742.00 |
| Sep 30, 2022 | -9,973.00 |
| May 31, 2022 | 4.55 Mn |
| Mar 31, 2022 | -18,097.00 |
| Dec 31, 2021 | -17,210.00 |
| Sep 30, 2021 | -13.99 Mn |
| Jun 30, 2021 | -11,972.68 |